Top Institutional Investors

ARMISTICE CAPITAL, LLC — 13F Holdings & Portfolio

CIK 1601086 · latest 13F-HR filed 2026-08-14

Backtest portfolio

ARMISTICE CAPITAL, LLC manages $8.17B in 13F-reported U.S. long-equity assets across 341 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (22.84%), IWM (17.64%), SPY (6.40%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 169 new positions and exited 97; 88 existing positions rose in reported value and 52 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$8.17B

Long-equity book

Holdings
341

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+169 / −97 / ↑88 / ↓52

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26
MDGL4.3% · +9%SUPN3.4% · +40%CYTK2.8% · +57%INCY2.8% · +37%NBIX2.5% · -26%TVTX2.5% · -68%AGIO2.5% · -12%PTCT2.4% · -48%UNH2.1% · +24%FRPT2.1% · +15%DYN1.9% · -3%AMZN1.9% · +9%IMVT1.9% · -51%RIGL1.8% · +31%TMO1.7% · +34%IRWD1.6% · -7%HRMY1.6% · -4%REGN1.5% · +149%NKTR1.4% · +25%MLYS1.3% · +48%SNY1.3% · +255%IMCR1.3% · +20%GOOGL1.3% · +7%SLDB1.2% · +34%MDB1.2% · +17%KURA1.1% · -2%XRAY1.1% · +22%UBER1.0% · -4%AXGN1.0% · -17%IRON0.9% · -14%GTLB0.9% · +4%FIVN0.9% · -4%HUBS0.9% · +38%ALGN0.8% · +14%MSFT0.8% · +65%OFIX0.8% · +21%HUM0.8% · -49%ANGO0.8% · +18%WAT0.8% · newVSTM0.7% · +53%FDMT0.7% · 0%NTLA0.7% · +346%WYNN0.7% · +50%TMCI0.7% · 0%AUTL0.7% · -5%ARVN0.6% · +41%MGNX0.6% · -17%ANRO0.6% · -5%TOST0.6% · +40%PATH0.6% · +56%GRFS0.6% · -2%CENTA0.6% · +12%TSM0.6% · -29%S0.6% · -36%LEN0.6% · +25%ISRG0.5% · -6%RH0.5% · +143%ZETA0.5% · +8678%WDAY0.5% · +108%NBIS0.5% · -38%

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 27.4%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 31, 2026.

Assets Under Management
$4.72B
Discretionary
$4.72B
Employees
30
Accounts
3
Address
510 MADISON AVE
7TH FLOOR
NEW YORK, NY 10022
Phone
(212) 231-4930
Website
This firm reports 1 disclosure item on its registration.
Name Title / Status Ownership Type
BAUTISTA, JOSE YLDEFONSO, MALLONGA ControlCHIEF COMPLIANCE OFFICER AND DEPUTY CHIEF FINANCIAL OFFICER
since May 2024
Less than 5%Individual
BOYD, STEVEN, JOSEPH ControlMANAGING MEMBER
since May 2012
75% or moreIndividual
CORDONE, ANTHONY, JOSEPH ControlCHIEF FINANCIAL OFFICER
since May 2012
Less than 5%Individual
MILLER, SCOTT, BENJAMIN ControlCHIEF OPERATING OFFICER
since Aug 2025
Less than 5%Individual
RUSSELL, MATTHEW, MACKAY ControlCHIEF OPERATING OFFICER
since Feb 2024
Less than 5%Individual
Ownership & leadership changes · 11 filings with changes since Oct 3, 2013

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 31, 2026 filing
  • AddedMILLER, SCOTT, BENJAMIN · CHIEF OPERATING OFFICER · Less than 5% · control person
May 31, 2024 filing
  • No longer listedBEZEK, SAMUEL, (NMN) · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Oct 2023
  • No longer listedRUSSELL, MATTHEW, MACKAY · CHIEF OPERATING OFFICER · Less than 5% · control person · listed since Feb 2024
  • AddedBAUTISTA, JOSE YLDEFONSO, MALLONGA · CHIEF COMPLIANCE OFFICER AND DEPUTY CHIEF FINANCIAL OFFICER · Less than 5% · control person
  • Listed againRUSSELL, MATTHEW, MACKAY · CHIEF OPERATING OFFICER · Less than 5% · control person
Mar 28, 2024 filing
  • AddedRUSSELL, MATTHEW, MACKAY · CHIEF OPERATING OFFICER · Less than 5% · control person
Oct 11, 2023 filing
  • No longer listedSEILER, KENNETH, LEE · CHIEF COMPLIANCE OFFICER & COUNSEL · Less than 5% · control person · listed since Mar 2023
  • AddedBEZEK, SAMUEL, (NMN) · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Mar 31, 2023 filing
  • No longer listedKOHN, BRIAN, THEODORE · CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL · Less than 5% · control person · listed since Oct 2020
  • AddedSEILER, KENNETH, LEE · CHIEF COMPLIANCE OFFICER & COUNSEL · Less than 5% · control person
Oct 27, 2020 filing
  • No longer listedRADDEN, DANIEL, SCOTT · GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Apr 2019
  • AddedKOHN, BRIAN, THEODORE · CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL · Less than 5% · control person
May 8, 2019 filing
  • AddedRADDEN, DANIEL, SCOTT · GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedCORDONE, ANTHONY, JOSEPH · title CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER
Mar 29, 2019 filing
  • No longer listedCHEN, TOHUAN, STEVE · CHIEF COMPLIANCE OFFICER/ CONTROLLER · Less than 5% · control person · listed since Mar 2018
  • ChangedCORDONE, ANTHONY, JOSEPH · title CHIEF FINANCIAL OFFICER → CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER
Mar 29, 2018 filing
  • AddedCHEN, TOHUAN, STEVE · CHIEF COMPLIANCE OFFICER/ CONTROLLER · Less than 5% · control person
  • ChangedCORDONE, ANTHONY, JOSEPH · title CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER
Jul 28, 2017 filing
  • No longer listedTHOMAS, EVAN, SHAWN · CHIEF COMPLIANCE OFFICER AND DIRECTOR OF OPERATIONS · Less than 5% · control person · listed since May 2014
  • ChangedCORDONE, ANTHONY, JOSEPH · title CHIEF FINANCIAL OFFICER → CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER
Older changes (2 more filings)
Mar 31, 2015 filing
  • AddedTHOMAS, EVAN, SHAWN · CHIEF COMPLIANCE OFFICER AND DIRECTOR OF OPERATIONS · Less than 5% · control person
  • ChangedCORDONE, ANTHONY, JOSEPH · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER
Oct 3, 2013 filing (earliest on record)
  • ListedBOYD, STEVEN, JOSEPH · MANAGING MEMBER · 75% or more · control person
  • ListedCORDONE, ANTHONY, JOSEPH · CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

ARMISTICE CAPITAL, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $1.87B 22.84% 2,500,000 SH
2 ISHARES TR Put IWM 464287655 $1.44B 17.64% 4,800,000 SH
3 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $522.7M 6.40% 700,000 SH
4 ISHARES TR Put IWM 464287655 $300.4M 3.68% 1,000,000 SH
5 SUPERNUS PHARMACEUTICALS SUPN 868459108 $123.1M 1.51% 2,646,201 SH
6 CYTOKINETICS INC Call CYTK 23282W605 $106.5M 1.30% 1,250,000 SH
7 AGIOS PHARMACEUTICALS INC Call AGIO 00847X104 $104.3M 1.28% 2,810,000 SH
8 CYTOKINETICS INC CYTK 23282W605 $102.3M 1.25% 1,201,342 SH
9 INCYTE CORP INCY 45337C102 $102.0M 1.25% 900,005 SH
10 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $90.3M 1.10% 535,838 SH
11 TRAVERE THERAPEUTICS INC TVTX 89422G107 $89.3M 1.09% 1,572,539 SH
12 AGIOS PHARMACEUTICALS INC AGIO 00847X104 $89.1M 1.09% 2,400,000 SH
13 PTC THERAPEUTICS INC PTCT 69366J200 $87.4M 1.07% 1,071,395 SH
14 UNITEDHEALTH GROUP INC UNH 91324P102 $76.1M 0.93% 183,000 SH
15 FRESHPET INC FRPT 358039105 $74.5M 0.91% 1,260,702 SH
16 DYNE THERAPEUTICS INC DYN 26818M108 $68.6M 0.84% 3,087,226 SH
17 AMAZON COM INC AMZN 023135106 $67.8M 0.83% 284,562 SH
18 IMMUNOVANT INC IMVT 45258J102 $66.9M 0.82% 1,736,000 SH
19 RIGEL PHARMACEUTICALS INC RIGL 766559702 $65.4M 0.80% 1,672,000 SH
20 THERMO FISHER SCIENTIFIC INC TMO 883556102 $61.4M 0.75% 122,480 SH
21 IRONWOOD PHARMACEUTICALS INC IRWD 46333X108 $58.7M 0.72% 13,932,000 SH
22 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $58.0M 0.71% 108,000 SH
23 HARMONY BIOSCIENCES HLDGS IN HRMY 413197104 $56.9M 0.70% 1,564,000 SH
24 REGENERON PHARMACEUTICALS REGN 75886F107 $56.0M 0.69% 89,809 SH
25 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $53.7M 0.66% 100,000 SH
26 NEKTAR THERAPEUTICS NKTR 640268306 $50.5M 0.62% 724,000 SH
27 MINERALYS THERAPEUTICS INC MLYS 603170101 $46.8M 0.57% 1,736,000 SH
28 SANOFI SA SNY 80105N105 $45.4M 0.56% 1,064,000 SH
29 IMMUNOCORE HLDGS PLC IMCR 45258D105 $45.3M 0.55% 1,428,000 SH
30 ALPHABET INC GOOGL 02079K305 $45.2M 0.55% 126,494 SH
31 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $43.0M 0.53% 80,000 SH
32 SOLID BIOSCIENCES INC SLDB 83422E204 $42.7M 0.52% 4,278,000 SH
33 MONGODB INC MDB 60937P106 $42.0M 0.51% 125,172 SH
34 KURA ONCOLOGY INC KURA 50127T109 $40.3M 0.49% 3,678,000 SH
35 DENTSPLY SIRONA INC XRAY 24906P109 $39.0M 0.48% 3,672,000 SH
36 UBER TECHNOLOGIES INC UBER 90353T100 $35.9M 0.44% 497,908 SH
37 AXOGEN INC AXGN 05463X106 $35.8M 0.44% 775,000 SH
38 DISC MEDICINE INC IRON 254604101 $33.6M 0.41% 460,000 SH
39 GITLAB INC GTLB 37637K108 $32.8M 0.40% 1,074,141 SH
40 FIVE9 INC FIVN 338307101 $32.7M 0.40% 1,536,000 SH
41 HUBSPOT INC HUBS 443573100 $32.5M 0.40% 178,047 SH
42 ALIGN TECHNOLOGY INC ALGN 016255101 $30.4M 0.37% 180,286 SH
43 MICROSOFT CORP MSFT 594918104 $30.1M 0.37% 80,581 SH
44 ORTHOFIX MED INC OFIX 68752M108 $29.8M 0.36% 3,264,000 SH
45 PTC THERAPEUTICS INC Call PTCT 69366J200 $29.4M 0.36% 360,000 SH
46 HUMANA INC HUM 444859102 $28.8M 0.35% 72,527 SH
47 ANGIODYNAMICS INC ANGO 03475V101 $28.6M 0.35% 2,198,000 SH
48 TRAVERE THERAPEUTICS INC Call TVTX 89422G107 $28.4M 0.35% 500,000 SH
49 WATERS CORP WAT 941848103 $28.1M 0.34% 75,004 SH
50 MINERALYS THERAPEUTICS INC Call MLYS 603170101 $28.1M 0.34% 1,040,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $8.17B 341 0001315863-26-000589
2026-03-31 2026-05-15 $5.62B 267 0001315863-26-000414
2025-12-31 2026-02-17 $8.40B 370 0001315863-26-000163
2025-09-30 2025-11-17 $6.74B 332 0001315863-25-000814
Filer Information
Address
510 MADISON AVENUE, 7TH FLOOR
NEW YORK, NY 10022
Phone
(212) 231-4932
Filing Manager
ARMISTICE CAPITAL, LLC
NEW YORK, NY
Signatory
Anthony Cordone
Chief Financial Officer